Novo Nordisk (NOVOB DC) to acquire Ocedurenone for uncontrolled hypertensions from KBP biosciences, for up to USD 1.3bln

16 Oct 2023 - 12:01- - Source: Newswires

NOVOB.DCNovo Nordisk A/SAsian SessionUSDUnited States

Subscribe Now to Newsquawk

Click here for a 1 week free trial

Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include: